Journal Club 2021

Share
Print
Share
Print

 

1/29/2021 - presented by Heather Jones

Antigen identification for HLA class I– and HLA class II–restricted T cell receptors using cytokine-capturing antigen-presenting cells.”

Article link


2/05/2021 - presented by Manish Malviya

Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells.”

Article link


2/19/2021 - presented by Megan Dacek

Modeling human adaptive immune responses with tonsil organoids.”

Article link


3/05/2021 - presented by Kristen Vogt

Regulatory T cells engineered with TCR signaling–responsive IL-2 nanogels suppress alloimmunity in sites of antigen encounter.”

Article link


3/19/2021 - presented by Keifer Kurtz

Robust SARS-CoV-2-specific T cell immunity is maintained at 6 months following primary infection.”

Article link


3/05/2021 - presented by Leila Peraro

Engineering Tolerance toward Allogeneic CAR-T Cells by Regulation of MHC Surface Expression with Human Herpes Virus-8 Proteins.”


4/09/2021 - presented by Christopher Bourne

AAV-Mediated In Vivo CAR Gene Therapy for Targeting Human T Cell Leukemia.”

Article link


4/16/2021 - presented by Pedro C. Silberman

Senolytic CAR T cells reverse senescence-associated pathologies.”

Article link


5/21/2021- presented by Zaki Molvi

“CD8+ T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope display high naive precursor frequency and TCR promiscuity.”

Article Link


6/04/2021- presented by Zita Aretz

“Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.”

Article Link